1. Introduction
===============

Premature ovarian failure (POF) is defined as the cessation of ovarian function before the age of 40, and is associated with elevated serum gonadotropin levels (follicle stimulating hormone (FSH) \>40 mIU/mL).^\[[@R1]\]^ Studies have reported that the incidence of POF stands at 0.01% before the age of 20,^\[[@R2]\]^ 0.1% before the age of 30, and 1% to 2% before the age of 40,^\[[@R3]\]^ with an average age of onset of 23.3 years.^\[[@R4]\]^ POF decreases the fertility of women within the reproductive age. In addition, it has serious health consequences, including autoimmune diseases, osteoporosis, infertility, ischemic heart disease, and increased cardiovascular diseases.^\[[@R5]--[@R7]\]^

Thus, early intervention should be initiated to prevent long-term consequences. POF is primarily treated with hormone replacement therapy (HRT).^\[[@R6]\]^ This approach alleviates the symptoms caused by the decline in various ovarian hormones levels in POF. However, HRT has been associated with many serious adverse effects such as breast cancer, heart attacks and stroke.^\[[@R3],[@R8]\]^

Acupuncture has been accepted by many people and is widely used to treat various diseases including back pain, arthritis, headache, asthma, and other female diseases.^\[[@R9]\]^ It modulates the menstrual cycle and up-regulates uterine electromyography, which in turn improves reproductive function.^\[[@R3],[@R4],[@R10]\]^ For this reason, is the most commonly used complementary therapies in many Western countries.^\[[@R9],[@R11]\]^

In recent years, acupuncture has been widely used in POF. Clinical studies show that it not only effectively decreases hot flashes and related symptoms,^\[[@R12]\]^ but also decreases serums FSH and luteinizing hormone (LH) level, raise serum estradiol (E2) level, relieve anxiety, reduce mental stress and improve the quality of life.^\[[@R13]\]^ Several systematic reviews^\[[@R14]--[@R16]\]^ have shown that acupuncture treatment improve ovarian function and serum sex hormone levels in POF patients significantly. In addition to traditional needle acupuncture, newer forms of acupuncture have been developed, including warm acupuncture, acupoint catgut embedding and moxibustion. Notably, previous systematic reviews^\[[@R14]--[@R16]\]^ have largely examined the efficacy of different acupuncture treatments as a whole. Clinically, the choice of acupuncture therapy is often based on the experience of the acupuncturists. The lack of evidence-based concepts that guide the choice of acupuncture often leads to poor outcomes.

It is therefore necessary to develop a more standardized approach to guide the clinical application of acupuncture for POF. Herein, we employed network meta-analysis (NMA) to compare the efficacy of acupuncture, warm acupuncture, acupoint catgut embedding and moxibustion in the treatment of POF.

2. Materials and methods
========================

2.1. Design and registration
----------------------------

This systematic review was reported with the Preferred Reporting Items for Systematic Review and Meta Analyses (PRISMA) Statement and was registered on the PROSPERO as CRD42020150508. (<http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42020150508>) This is a systematic review and ethical approval is not necessary.

2.2. Ethic approval
-------------------

No ethical issues are foreseen because this study does not involve clinical trials. The research data is from published papers.

2.3. Inclusion Criteria
-----------------------

### 2.3.1. (1) Participants

Patients who were diagnosed and met the criteria of POF;^\[[@R17]--[@R22]\]^ mainly with amenorrhea for over four months, FSH above 40 IU/L as detected at least 2 times, and younger than 40 years.

### 2.3.2. (2) Interventions and Comparison

The treatment group was treated with acupuncture, warm acupuncture, electroacupuncture, moxibustion or acupoint catgut embedding alone. The control group was treated with conventional medicine or 1 of the above-mentioned acupuncture treatments.

### 2.3.3. (3) Outcomes

The primary outcome measurement was based on the improvement in symptoms and serum index.

Effectiveness rate = (total points of symptom before treatment- total points of symptom after treatment)/ total points of symptom before treatment × 100%.

Total effective rate = (number of healing cases+ number of markedly effective cases + number of effective cases)/ total number of cases × 100%.

1.  Healing: Clinical symptoms and signs disappeared, menstrual cycle, serum FSH, E2 levels returned to normal, and the total effective rate of≥95%;

2.  Markedly effective: Clinical symptoms and signs were significantly improved, menstrual cycle, serum FSH and E2 levels were significantly improved, 70%≤total effective rate \< 95%;

3.  Effective: Clinical signs and symptoms were slightly improved, menstrual cycle, serum FSH and E2 levels were slightly improved, 30% ≤ total effective rate \< 70%;

4.  Invalid: There was no improvement in clinical signs and symptoms, no improvement in menstrual cycle, no improvement in serum FSH and E2 levels, total effective rate \< 30%.

The second outcome measures included Serum FSH, E2, and LH.

The second outcome measure included Serum follicle-stimulating hormone (FSH), E2 and LH.

2.4. Data source and Search strategy
------------------------------------

We searched PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, VIP Chinese Science, WanFang, and Chinese Biomedical Literature databases from the date of their inception to January 13, 2020. The languages used for the trials were restricted to English or Chinese. According to the characteristics of each database, MeSH terms were combined with free words:("acupuncture" OR "moxibustion" OR "electroacupuncture" OR "acupoint catgut embedding" OR "warm Acupuncture") AND "premature ovarian failure" OR "Premature Menopause" AND "Randomized Controlled Trial" OR "Randomized."

2.5. Study selection and data extraction
----------------------------------------

First, all the screened studies were imported into Note Express. Studies that were repeated and did not meet the inclusion criteria were excluded after reading the title and abstract. The full text was screened again according to the inclusion and exclusion criteria. Data extraction was done by 2 authors, independently. The content contained the authors' names, publication date, diagnostic criteria, the number of the experimental and control group, gender, age, course of the diseases, intervention, control group type, outcome indicators, the evaluation standard, and so on. Study characteristics (author and year of publication); participant characteristics (age, disease course, and cases of each group); intervention information (measures of intervention and control, treatment duration, adverse events) and outcome. In case of inconsistency in the data, a third author was called to verify.

2.6. Risk of bias in individual studies
---------------------------------------

Two reviewers assessed the risk of bias of the randomized controlled trial (RCTs) using the Cochrane Collaboration tool for assessing the risk of bias.^\[[@R23]\]^ Each study was evaluated for low, unclean and high-risk bias based on 7 items:

1.  random sequence generation;

2.  allocation concealment;

3.  blinding of participants and personnel;

4.  blinding of outcome assessment;

5.  incomplete outcome data;

6.  selective reporting; and

7.  other bias.

Any disagreement was addressed by the third reviewer. The risk of bias assessment was performed using Review Manager 5.3.

2.7. Statistical analysis
-------------------------

Randomized effects model was used for pairwise meta-analysis for each pair of interventions, using Review Manager 5.3.3 (Cochrane Collaboration, Denmark). Odds ratios (OR) were used to analyze dichotomous outcomes, standard mean differences (SMDs) for continuous outcomes and 95% confidence intervals to estimate relative treatment effectiveness.

A NMA was performed in STATA 14.0. The network evidence graph was implemented through the command 'netplot'. Differences between direct and indirect evidence for the same comparisons were explored according to the results of I2 and P-value of the global consistency, and then the node-splitting analysis method was used to assess inconsistency between direct and indirect comparisons of each pair of interventions.^\[[@R24]\]^ Finally, the inconsistency factor within each closed loop of evidence was used to detect inconsistency among studies, while direct and indirect comparisons were used for the same study.^\[[@R25]\]^ The surface under the cumulative ranking curves (SUCRA) and mean rank (MR) were used as the evaluation indexes. The SUCRA value was the index reflecting the possibility of the intervention measures. The closer MR was to 0, the better the effect of the intervention. *P* \< .05 was considered statistically significant.^\[[@R26]\]^

We used a comparison-adjusted funnel plot to determine whether there was a small sample effect or publication bias in the network.

3. Results
==========

3.1. Study selection and characteristics
----------------------------------------

As shown in Figure [1](#F1){ref-type="fig"}, our systematic search identified 408 articles; 16 studies, published between 1979 and 2019 and involving 1307 patients, were eligible. Patients' age ranged from 26 to 40 years old; the course of disease ranging from 86 days to 11 years; and the study sample size ranged from 10 to 52 patients. In terms of interventions, 16 studies compared acupuncture and HRT, and all were 2-arm studies; nine involved acupuncture, one warm acupuncture, four acupoint catgut embedding, and two acupuncture and moxibustion. The characteristics of each study are presented in Table [1](#T1){ref-type="table"}.

![Flow chart of studies considered for inclusion.](medi-99-e20958-g001){#F1}

###### 

Characteristics of the included RCTs.

![](medi-99-e20958-g002)

3.2. Risk of bias of the Included Studies
-----------------------------------------

In terms of random sequence generation, four studies (35%)^\[[@R27],[@R28],[@R30],[@R34],[@R42]\]^ reported an appropriate method for randomization, 2 addressed admission^\[[@R29],[@R41]\]^ and therefore high risk, the rest only reported random, so it is not clear. Allocation concealment and blind were only reported in one study,^\[[@R34]\]^ the rest were not reported. None of the studies made efforts to blind the personnel or the participants. All studies were not registered in advance or planned; therefore, selective outcome reporting was not clear. Therefore, the overall risk bias is unclear. The risk of bias summary is listed in Figure [2](#F2){ref-type="fig"}.

![Network meta-analysis of eligible comparisons.](medi-99-e20958-g003){#F2}

3.3. Results of NMA
-------------------

### 3.3.1. Pairwise meta-analysis

Table [2](#T2){ref-type="table"} and Supplemental Content 1, Available at present the results of the pairwise meta-analysis and heterogeneity estimates. All 16 studies reported effective rate, 10 reported LH, and 14 reported E2 and FSH.

###### 

Pairwise meta-analyses.

![](medi-99-e20958-g004)

The forest plot of effective rate indicates that acupuncture (OR 4.47, 2.97 to 6.72, I2 =0%) and acupoint catgut embedding (OR 3.68,1.71 to 7.93, I2 =11%) were more efficacious than HRT.

The forest plot of LH indicates that acupuncture (SMD -6.31, -7.97 to -4.66, I2 = 58%) had significantly higher improvement than HRT. were associated with a

The forest plot of E2 indicates that acupuncture (SMD 20.46, 18.15 to 22.77, I2 = 98%) was superior to HRT, however, acupoint catgut embedding (SMD -8.06, -10.88 to -5.23, I2 = 92%) had a worse effect than HRT.

The forest plot of FSH indicates that acupuncture (SMD -11.30, -13.60 to -8.99, I2 = 83%), acupoint catgut embedding (SMD 17.18,11.82 to 22.53, I2 = 98%), acupuncture (SMD 4.73, 0.40 to 9.06) and moxibustion show lower FSH than HRT.

Sensitivity analysis was performed for paired studies with *I*^2^ greater than 50%, removing any single study one by one. The results did not change significantly, indicating that the pooled results were stable.

### 3.3.2. NMA

#### 3.3.2.1. (1) Effective rate

Figure [3](#F3){ref-type="fig"}A shows network results of treatment comparisons for the effective rate. The results of the NMA for the effective rate are presented in Table [2](#T2){ref-type="table"}. A total of 16 RCTs (1307 participants) were analyzed.

![Summary of the risk of bias.](medi-99-e20958-g005){#F3}

The results of NMA indicate that warm acupuncture and HRT have improved efficiency compared to acupoint embedding, and embedding is more efficient than HRT. The rest of the comparisons had no statistically significant difference (Table [3](#T3){ref-type="table"}).

###### 

Network meta-analysis comparisons of effective rate and FSH.

![](medi-99-e20958-g006)

According to SUCRA, acupuncture (97.3%) had the highest effective rate, followed by acupoint catgut embedding (58.8%), acupuncture with moxibustion (53.6%), warm acupuncture (29.2%) and HRT (11.1%) (Supplemental Content 2).

#### 3.3.2.2. (2) FSH

Figure [3](#F3){ref-type="fig"}b shows the network plot of treatment comparisons for FSH. The results of NMA for the effective rate are presented in Table [2](#T2){ref-type="table"}. A total of 14 RCTs (1024 participants) were analyzed for FSH changes. NMA indicated that acupuncture is more effective in reducing FSH than warm acupuncture and HRT. There were no statistically significant differences among other comparisons on FSH (Table [3](#T3){ref-type="table"}).

According to the SUCRA, acupuncture (96.7%) had the highest probability of reducing FSH, followed by acupoint catgut embedding (64.9%), HRT (37.5%), warm acupuncture (30.1%) and acupuncture and moxibustion (20.7%) (Supplemental Content 3).

#### 3.3.2.3. (3) E2

Figure [3](#F3){ref-type="fig"}C, shows network plot of treatment comparisons for E2. The results of NMA for the effective rate are presented in Table [2](#T2){ref-type="table"}. A total of 14 RCTs (1024 participants) were analyzed for E2. NMA indicates that acupoint embedding and acupuncture can improve E2 more effectively than HRT. There was no statistically significant difference among other comparisons on the E2 (Table [4](#T4){ref-type="table"}).

###### 

Network meta-analysis comparisons of E2 and LH.

![](medi-99-e20958-g007)

According to the SUCRA, acupoint catgut embedding (89.3%) and acupuncture (70.6%) ranked in the top 2 positions for effectiveness on E2, followed by acupuncture and moxibustion (36.5%), warm acupuncture (27.9%) and HRT (25.7%) (Supplemental Content 4, Available at).

#### 3.3.2.4. (4) LH

Figure [3](#F3){ref-type="fig"}D shows the network plot of treatment comparisons for LH. The results of NMA for the LH are presented in Table [2](#T2){ref-type="table"}. A total of 10 RCTs (713 participants) were analyzed for LH. NMA indicates that acupuncture is superior to HRT in reducing LH. There was no statistically significant difference between acupoint catgut embedding and HRT on LH (Table [4](#T4){ref-type="table"}).

According to SUCRA, acupuncture (94%) had the highest probability in reducing LH, followed by acupoint catgut embedding (30.8%), and HRT (25.3%) (Supplemental Content 5, Available at).

### 3.3.3. Evaluation of Statistical Inconsistency

Side-splitting did not indicate any statistical inconsistency for any outcomes (Supplemental Content 6, Available at).

### 3.3.4. Small-study effects

In general, there was no strong evidence effects of the small study across outcomes.

However, among the outcome indicators of FSH and E2, several studies on the lateral side of the funnel plot may be related to the heterogeneity between studies (Supplemental Content 7, Available at).

### 3.3.5. Sensitivity analysis

Supplemental Content 8, Available at presents the results of the sensitivity analyses. Excluding 2 studies with high-risk bias resulting from the inappropriate random method did not significantly change our results about effective rate and FSH.

4. Discussion
=============

The purpose of this study was to compare the efficacy of different acupuncture treatments in the treatment of POF. Numerous systematic reviews^\[[@R14]--[@R16]\]^ have shown that acupuncture-related therapies are superior to western drugs in improving POF, although such conclusion has been obtained for the entire range of acupuncture treatments as a whole. In this study, we ranked the efficacy of different acupuncture therapies using NMA. In so-doing, we provide the specific clinical efficacy of each acupuncture technique.

In study, 16 RCTS, involving 1307 patients were examined. NMA showed that acupuncture was the most effective with the best FSH reduction level. Among the 4 acupuncture treatments; acupuncture and acupoint embedding were the first and second most effective in improving E2; whereas acupuncture was superior to acupoint embedding and HRT in decreasing LH. Most importantly, these conclusions did not change significantly after sensitivity analysis.

Numerous studies have explored the mechanism of action of acupuncture in the treatment of POF. The mechanism of acupuncture therapy for POF is described according to the types of acupuncture. Acupuncture defined as a procedure in which specific body areas, the acupoints (also called meridian points), are pierced with fine needles to induce a therapeutic response. It has been found that acupuncture activates the dopamine system in the brain and finetunes the function of HPOA. In this way, acupuncture alters normalizes the physiological functions.^\[[@R43]\]^ In ovariectomized rats, Cheng et al^\[[@R44]\]^ found that acupuncture increased low estrogen levels and reduced high gonadotropin levels. Li et al compared the effects of acupuncture and diethylstilbestrol on sex hormones in rats with POF.^\[[@R45]\]^ They found that acupuncture significantly increased uterine wall thickness and improved uterine blood circulation in rats. Thus, acupuncture improves the reproductive organs in POF rats, and normalizes sex hormones levels. Acupoint catgut embedding involves the implantation of a sheep gut or other absorbable thread to an acupuncture point in line with the theory of acupuncture and meridian. Acupoint embedding on acupoints reduces FSH and LH levels and increases E2 by stimulating the acting on the hypothalamic-pituitary-ovarian axis system. Acupoint embedding also regulates paracrine and/or autocrine functions through stem cell factors, thereby improving the ovarian microenvironment.^\[[@R46],[@R47]\]^ Acupoint catgut embedding has been observed to improve ovarian blood supply, inhibit follicular atresia, promote follicular development and recruitment, increase the nutrition of ovarian granulosa cells, enhance the activity of aromatase of the follicular membrane cells granulosa cells, convert androgens into estrogen, leading to elevation in E2 levels in blood.^\[[@R10]\]^ Warm acupuncture approach combines acupuncture with moxibustion. In this therapy, a moxa column is added to the end of a needle, ignites it and the heat is transmitted through the needle to the body to treat diseases. Chen^\[[@R48]\]^ found that warm acupuncture not only simultaneously confer acupuncture therapy and moxibustion therapy. Warm acupuncture regulates increases E2 and progesterone, inhibits the secretion of LH, establishing a negative feedback loop between ovary and pituitary. This loop normalizes elevated FSH, balances the HPO axis and enhances the body\'s immunity.^\[[@R49]\]^. In acupuncture and moxibustion, is a combination of acupuncture and moxibustion to treat diseases. Moxibustion is a method in which a moxa herb is burned above the skin or on the acupuncture points. Moxibustion can promotes blood circulation and removes blood stasis by regulating the constriction of blood vessels.^\[[@R50]\]^ One study^\[[@R51]\]^ found that moxibustion at guan yuan restored the function of the hypothalamic-pituitary-ovarian axis to normal level mainly by promoting the synthesis of E2. Elsewhere,^\[[@R52]\]^ acupuncture combined with moxibustion improved the estrogen level and estrogen receptor protein levels. In this way, the combination therapy regulated the HPO axis and endocrine function, thereby improving the ovarian function.

Despite the findings mentioned in this study, the following limitations should be mentioned: First, this study was conducted on a relatively small sample size, ranging from 10 to 52 patients. Thus, to increase the reliability of our results, further studies with larger sample size are warranted. Second, the risk of bias for most of the included RCTs is not clear, especially biases related to randomization, allocation, concealment, and blinding, which might decrease the credibility of our conclusions. Future clinical trials compliant to the CONSORT reporting system are advocated to validate our findings.^\[[@R52]\]^ Thirdly, heterogeneity cannot be ruled out given the differences in acupoints, technique and treatment frequency used across studies. In addition, the studies included were conducted in China and all participants were Chinese, which affects sampling and limits extrapolation of our results to other populations. Future clinical trials on acupuncture conforming to the Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA)^\[[@R53]\]^ are advocated across countries and regions to provide more conclusive and reliable results. Fourth, there are only indirect comparisons among acupuncture treatment, which reduces the credibility of our conclusions. Future head-to-head trials on acupuncture therapies should be performed to provide more compelling evidence to guide the clinical application of acupuncture.

5. Conclusion
=============

Clinical evidence, summarized using NMA, indicates that acupuncture has the highest probability of being the most effective therapy for improving menopausal symptoms and decreasing FSH and LH levels. Therefore, acupuncture is an effective alternative for patients with POF, who are intolerant to hormone replacement therapy or who would prefer alternative and complementary therapies. Moreover, further multi-center and high-quality RCT studies should be conducted to contribute more details.
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